- Release Date: 17/04/24 09:50
- Summary: Phase II/III ASD Trial Successfully Meets Primary Endpoint
- Price Sensitive: Yes
- Download Document 361.07KB
Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $33.62K | 629.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3755572 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 120107 | 3 |
View Market Depth
| Last trade - 14.27pm 08/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |